{"id":"https://openalex.org/W2003719684","doi":"https://doi.org/10.3109/10428194.2015.1014368","title":"Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma","display_name":"Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma","publication_year":2015,"publication_date":"2015-02-11","ids":{"openalex":"https://openalex.org/W2003719684","doi":"https://doi.org/10.3109/10428194.2015.1014368","mag":"2003719684","pmid":"https://pubmed.ncbi.nlm.nih.gov/25669927","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4835239"},"language":"en","primary_location":{"id":"doi:10.3109/10428194.2015.1014368","doi":"https://doi.org/10.3109/10428194.2015.1014368","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2015.1014368","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4835239","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059854479","display_name":"Farrukh Tauseef Awan","orcid":"https://orcid.org/0000-0003-1813-9812","observed_orcids":["https://orcid.org/0000-0003-1813-9812"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farrukh T. Awan","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019749214","display_name":"Joseph M. Flynn","orcid":"https://orcid.org/0000-0003-1767-9235","observed_orcids":["https://orcid.org/0000-0003-1767-9235"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Flynn","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102896676","display_name":"Jeffrey Alan Jones","orcid":"https://orcid.org/0000-0001-9557-0820","observed_orcids":["https://orcid.org/0000-0001-9557-0820"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Jones","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039283256","display_name":"Leslie Ann Andritsos","orcid":"https://orcid.org/0000-0003-0222-1766","observed_orcids":["https://orcid.org/0000-0003-0222-1766"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie A. Andritsos","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kami J. Maddocks","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112301145","display_name":"Ellen J. Sass","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen J. Sass","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079982309","display_name":"Margaret S. Lucas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret S. Lucas","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052914850","display_name":"Weihong Chase","orcid":"https://orcid.org/0000-0002-9744-9562","observed_orcids":["https://orcid.org/0000-0002-9744-9562"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weihong Chase","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061042692","display_name":"Sharon Waymer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Waymer","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039919471","display_name":"Yonghua Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yonghua Ling","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103071641","display_name":"Yao Jiang","orcid":"https://orcid.org/0000-0002-5254-550X","observed_orcids":["https://orcid.org/0000-0002-5254-550X"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yao Jiang","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066257150","display_name":"Mitch A. Phelps","orcid":"https://orcid.org/0000-0002-1615-5280","observed_orcids":["https://orcid.org/0000-0002-1615-5280"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitch A. Phelps","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103532728","display_name":"David M Lucas","orcid":"https://orcid.org/0000-0001-8201-0808","observed_orcids":["https://orcid.org/0000-0001-8201-0808"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Lucas","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":["a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a The Ohio State University Comprehensive Cancer Center , Columbus , OH , USA","institution_ids":["https://openalex.org/I2799885155"]},{"raw_affiliation_string":"The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;","institution_ids":["https://openalex.org/I2799885155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014241029"],"corresponding_institution_ids":["https://openalex.org/I2799885155"],"apc_list":null,"apc_paid":null,"fwci":1.7469,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.83756884,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"56","issue":"10","first_page":"2834","last_page":"2840"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8899999856948853},{"id":"https://openalex.org/keywords/relapsed-chronic-lymphocytic-leukemia","display_name":"relapsed chronic lymphocytic leukemia","score":0.9589999914169312},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9419999718666077},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":1.0},{"id":"https://openalex.org/keywords/fludarabine-resistance","display_name":"fludarabine resistance","score":0.9779999852180481},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.8868757486343384},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8517848253250122},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7139486074447632},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.5989413857460022},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5023021697998047},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4819636046886444},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.39581066370010376},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3923470973968506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3922465741634369},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3268704414367676}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007143","descriptor_name":"Immunoglobulin Heavy Chains","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3109/10428194.2015.1014368","doi":"https://doi.org/10.3109/10428194.2015.1014368","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2015.1014368","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:25669927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25669927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:europepmc.org:3803158","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4835239","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4835239","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4835239","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Leuk Lymphoma","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3803158","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4835239","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2606285615","display_name":"Experimental Therapeutics of Leukemia","funder_award_id":"P50CA140158","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1802312641","https://openalex.org/W1965344560","https://openalex.org/W1976015013","https://openalex.org/W1987378323","https://openalex.org/W1991558827","https://openalex.org/W2002191848","https://openalex.org/W2016742872","https://openalex.org/W2027161615","https://openalex.org/W2033944464","https://openalex.org/W2058607565","https://openalex.org/W2065479731","https://openalex.org/W2065480848","https://openalex.org/W2066564017","https://openalex.org/W2067064694","https://openalex.org/W2071549499","https://openalex.org/W2078699393","https://openalex.org/W2082617142","https://openalex.org/W2087157354","https://openalex.org/W2095447519","https://openalex.org/W2096207943","https://openalex.org/W2108206643","https://openalex.org/W2125877270","https://openalex.org/W2126267349","https://openalex.org/W2130610418","https://openalex.org/W2130794506","https://openalex.org/W2140395974","https://openalex.org/W2142099365","https://openalex.org/W2147422161","https://openalex.org/W2157739482","https://openalex.org/W2159831275","https://openalex.org/W2163553489","https://openalex.org/W2164706843","https://openalex.org/W2171791219","https://openalex.org/W4232326942"],"related_works":["https://openalex.org/W2602388932","https://openalex.org/W2125877270","https://openalex.org/W1008795755","https://openalex.org/W2164706843","https://openalex.org/W2980882990","https://openalex.org/W2556475996","https://openalex.org/W2587572697","https://openalex.org/W2087157354","https://openalex.org/W2982932282","https://openalex.org/W2088675711"],"abstract_inverted_index":{"The":[0,106],"proteasome":[1,25],"complex":[2],"degrades":[3],"proteins":[4],"involved":[5],"in":[6,18,36,53,73,141],"a":[7,14,23,40],"variety":[8],"of":[9,51,91,139],"cellular":[10],"processes":[11],"and":[12,49,79,89,99,113,127,135,143],"is":[13,22],"powerful":[15],"therapeutic":[16],"target":[17],"several":[19],"malignancies.":[20],"Carfilzomib":[21],"potent":[24],"inhibitor":[26],"which":[27],"induces":[28],"rapid":[29],"chronic":[30],"lymphocytic":[31,58],"leukemia":[32],"(CLL)":[33],"cell":[34],"apoptosis":[35],"vitro.":[37],"We":[38],"conducted":[39],"phase":[41],"I":[42],"dose-escalation":[43],"trial":[44,131],"to":[45],"determine":[46],"the":[47],"safety":[48],"tolerability":[50,134],"carfilzomib":[52,66,140],"relapsed/refractory":[54],"CLL":[55,142],"or":[56],"small":[57],"lymphoma":[59],"(SLL).":[60],"Nineteen":[61],"patients":[62,116,124],"were":[63,104,111],"treated":[64],"with":[65,125],"initially":[67],"at":[68],"20":[69],"mg/m(2),":[70],"then":[71],"escalated":[72],"four":[74],"cohorts":[75],"(27,":[76],"36,":[77],"45":[78],"56":[80],"mg/m(2))":[81],"on":[82],"days":[83],"1,":[84],"2,":[85],"8,":[86],"9,":[87],"15":[88],"16":[90],"28-day":[92],"cycles.":[93],"Therapy":[94],"was":[95],"generally":[96],"well":[97],"tolerated,":[98],"no":[100],"dose":[101],"limiting":[102],"toxicities":[103,110],"observed.":[105],"most":[107],"common":[108],"hematologic":[109],"thrombocytopenia":[112],"neutropenia.":[114],"All":[115],"evaluable":[117],"for":[118],"response":[119],"had":[120],"stable":[121],"disease,":[122],"including":[123],"del17p13":[126],"fludarabine-resistant":[128],"disease.":[129],"This":[130],"shows":[132],"acceptable":[133],"limited":[136],"preliminary":[137],"efficacy":[138],"SLL.":[144]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}